FI20070795A0 - Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin - Google Patents

Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Info

Publication number
FI20070795A0
FI20070795A0 FI20070795A FI20070795A FI20070795A0 FI 20070795 A0 FI20070795 A0 FI 20070795A0 FI 20070795 A FI20070795 A FI 20070795A FI 20070795 A FI20070795 A FI 20070795A FI 20070795 A0 FI20070795 A0 FI 20070795A0
Authority
FI
Finland
Prior art keywords
therapies
assessing
effectiveness
disease development
monitoring disease
Prior art date
Application number
FI20070795A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Sirpa Jalkanen
Marko Salmi
Markku Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Priority to FI20070795A priority Critical patent/FI20070795A0/fi
Publication of FI20070795A0 publication Critical patent/FI20070795A0/fi
Priority to PT12002502T priority patent/PT2503338E/pt
Priority to SI200830723T priority patent/SI2201376T1/sl
Priority to JP2010530497A priority patent/JP4982610B2/ja
Priority to PL12002502T priority patent/PL2503338T3/pl
Priority to HRP20120743AT priority patent/HRP20120743T1/hr
Priority to US12/679,785 priority patent/US20100209942A1/en
Priority to KR1020107006430A priority patent/KR20100059902A/ko
Priority to DK12002502T priority patent/DK2503338T3/en
Priority to ES08842581T priority patent/ES2389751T3/es
Priority to PCT/FI2008/050576 priority patent/WO2009053523A1/en
Priority to ES12002502.8T priority patent/ES2532361T3/es
Priority to EP12002502.8A priority patent/EP2503338B1/en
Priority to DK08842581.4T priority patent/DK2201376T3/da
Priority to PL08842581T priority patent/PL2201376T3/pl
Priority to EP08842581A priority patent/EP2201376B1/en
Priority to SI200831377T priority patent/SI2503338T1/sl
Priority to PT08842581T priority patent/PT2201376E/pt
Priority to KR1020167005473A priority patent/KR20160029869A/ko
Priority to CA2702635A priority patent/CA2702635A1/en
Priority to JP2012098081A priority patent/JP5619810B2/ja
Priority to CY20121100924T priority patent/CY1113403T1/el
Priority to US13/775,558 priority patent/US8975081B2/en
Priority to HRP20150181TT priority patent/HRP20150181T1/hr
Priority to CY20151100234T priority patent/CY1116089T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
FI20070795A 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin FI20070795A0 (fi)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
CA2702635A CA2702635A1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
PCT/FI2008/050576 WO2009053523A1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
EP12002502.8A EP2503338B1 (en) 2007-10-24 2008-10-15 CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
JP2010530497A JP4982610B2 (ja) 2007-10-24 2008-10-15 疾患の進展をモニターするための、および治療法の有効性を評価するための新規なバイオマーカー
PL12002502T PL2503338T3 (pl) 2007-10-24 2008-10-15 CD73 jako biomarker do monitorowania rozwoju choroby i oceny skuteczności terapii
HRP20120743AT HRP20120743T1 (hr) 2007-10-24 2008-10-15 Novi biomarker za nadzor razvoja bolesti i procjenu uäśinkovitosti lijeäśenja
US12/679,785 US20100209942A1 (en) 2007-10-24 2008-10-15 New biomarker for monitoring development of diseases and assessing the efficacy of therapies
KR1020107006430A KR20100059902A (ko) 2007-10-24 2008-10-15 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
DK12002502T DK2503338T3 (en) 2007-10-24 2008-10-15 CD73 as a biomarker to monitor the development of disease and evaluate the effectiveness of treatments
ES08842581T ES2389751T3 (es) 2007-10-24 2008-10-15 Un nuevo biomarcador para monitorizar el desarrollo de enfermedades y evaluar la eficacia de terapias
PT12002502T PT2503338E (pt) 2007-10-24 2008-10-15 Cd73 para monitorizar o desenvolvimento de doenças e avaliar a eficácia de terapias
ES12002502.8T ES2532361T3 (es) 2007-10-24 2008-10-15 CD73 como biomarcador para monitorizar el desarrollo de enfermedades y evaluar la eficacia de terapias
SI200830723T SI2201376T1 (sl) 2007-10-24 2008-10-15 Nov biomarker za monitoring razvoja bolezni in določanje učinkovitosti terapij
DK08842581.4T DK2201376T3 (da) 2007-10-24 2008-10-15 En ny biomarkør til overvågning af udviklingen af sygdomme og vurdering af effektiviteten af terapier
PL08842581T PL2201376T3 (pl) 2007-10-24 2008-10-15 Nowy biomarker do monitorowania rozwoju chorób i do oceny skuteczności leczenia
EP08842581A EP2201376B1 (en) 2007-10-24 2008-10-15 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
SI200831377T SI2503338T1 (sl) 2007-10-24 2008-10-15 CD73 kot biomarker za spremljanje razvoja bolezni in ocenjevanje učinkovitosti terapij
PT08842581T PT2201376E (pt) 2007-10-24 2008-10-15 Um novo biomarcador para monitorizar o desenvolvimento de doenças e avaliar a eficácia de tratamentos
KR1020167005473A KR20160029869A (ko) 2007-10-24 2008-10-15 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
JP2012098081A JP5619810B2 (ja) 2007-10-24 2012-04-23 疾患の進展をモニターするための、および治療法の有効性を評価するための新規なバイオマーカー
CY20121100924T CY1113403T1 (el) 2007-10-24 2012-10-04 Νεος βιοδεικτης για την παρακολουθηση της εξελιξης των νοσων και την εκτιμηση της αποτελεσματικοτητας των θεραπειων
US13/775,558 US8975081B2 (en) 2007-10-24 2013-02-25 Biomarker for monitoring development of diseases and assessing the efficacy of therapies
HRP20150181TT HRP20150181T1 (hr) 2007-10-24 2015-02-16 Cd73 kao biomarker za praä†enje razvoja bolesti i procjenu uäśinkovitosti lijeäśenja
CY20151100234T CY1116089T1 (el) 2007-10-24 2015-03-06 Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Publications (1)

Publication Number Publication Date
FI20070795A0 true FI20070795A0 (fi) 2007-10-24

Family

ID=38656804

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20070795A FI20070795A0 (fi) 2007-10-24 2007-10-24 Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin

Country Status (14)

Country Link
US (1) US20100209942A1 (enExample)
EP (2) EP2201376B1 (enExample)
JP (2) JP4982610B2 (enExample)
KR (2) KR20160029869A (enExample)
CA (1) CA2702635A1 (enExample)
CY (2) CY1113403T1 (enExample)
DK (2) DK2201376T3 (enExample)
ES (2) ES2532361T3 (enExample)
FI (1) FI20070795A0 (enExample)
HR (2) HRP20120743T1 (enExample)
PL (2) PL2503338T3 (enExample)
PT (2) PT2503338E (enExample)
SI (2) SI2503338T1 (enExample)
WO (1) WO2009053523A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2878025C (en) 2008-01-18 2018-12-11 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
CA2806301A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting cardiovascular diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
BR112015018213B1 (pt) * 2013-02-14 2022-12-20 Faron Pharmaceuticals Oy Métodos para determinar a síndrome da angústia respiratória aguda (ards) e para monitorar o desenvolvimento desta e kit para diagnóstico
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
DK3221363T3 (da) 2014-11-21 2020-08-10 Bristol Myers Squibb Co Antistoffer mod cd73 og anvendelser deraf
HRP20201756T8 (hr) 2014-11-21 2021-08-20 Bristol-Myers Squibb Company Antitijela koja sadrže modificirane regije teškog lanca
GB201706747D0 (en) * 2017-04-27 2017-06-14 Queen Mary Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in idividual patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854934A4 (en) * 1995-08-18 2000-09-06 Donald W Landry DETECTION OF ORGANIC COMPOUNDS BY REGULATION OF ANTIBODY CATALYZED REACTIONS
WO1997013875A1 (en) * 1995-10-13 1997-04-17 Imperial College Of Science, Technology & Medicine Methods for predicting the outcome of persistent hbv infection and the outcome of cytokine therapy
HUP0002003A3 (en) * 2000-05-24 2003-01-28 Pronuk Biotechnologia Kft Process and reagent-kit for determining of 5'-nucleotidase activity
WO2002077174A2 (en) * 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
WO2004079013A1 (en) * 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
PL1608400T3 (pl) * 2003-03-28 2010-11-30 Faron Pharmaceuticals Oy Podwyższanie poziomu adenozyny przez indukowaną przez cytokiny ekspresję CD73
FI20030467A0 (fi) * 2003-03-28 2003-03-28 Sirpa Jalkanen Menetelmä tulehdustilojen hoitamiseen
EP1664073A2 (en) * 2003-06-03 2006-06-07 The Regents of the University of California Compositions and methods for treatment of disease with acetylated disaccharides
ATE520979T1 (de) * 2005-08-24 2011-09-15 Bristol Myers Squibb Co Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
FI20051003A0 (fi) 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
WO2007107598A1 (en) * 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
EP2041574B1 (en) * 2006-07-14 2016-11-16 The Regents of The University of California Cancer biomarkers and methods of use threof

Also Published As

Publication number Publication date
KR20160029869A (ko) 2016-03-15
EP2201376B1 (en) 2012-08-08
EP2503338A3 (en) 2013-03-13
DK2201376T3 (da) 2012-10-15
EP2201376A1 (en) 2010-06-30
CA2702635A1 (en) 2009-04-30
ES2389751T3 (es) 2012-10-31
JP2011501176A (ja) 2011-01-06
EP2201376A4 (en) 2011-03-23
PL2201376T3 (pl) 2013-01-31
CY1113403T1 (el) 2016-06-22
DK2503338T3 (en) 2015-03-09
CY1116089T1 (el) 2017-02-08
HRP20120743T1 (hr) 2012-10-31
SI2503338T1 (sl) 2015-06-30
PT2503338E (pt) 2015-03-05
US20100209942A1 (en) 2010-08-19
EP2503338A2 (en) 2012-09-26
JP4982610B2 (ja) 2012-07-25
PL2503338T3 (pl) 2015-06-30
KR20100059902A (ko) 2010-06-04
JP2012159514A (ja) 2012-08-23
HRP20150181T1 (hr) 2015-06-19
EP2503338B1 (en) 2014-12-24
JP5619810B2 (ja) 2014-11-05
SI2201376T1 (sl) 2012-09-28
WO2009053523A1 (en) 2009-04-30
PT2201376E (pt) 2012-08-20
ES2532361T3 (es) 2015-03-26

Similar Documents

Publication Publication Date Title
FI20070795A0 (fi) Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
DK2185068T3 (da) Fosterovervågning
NO345031B1 (no) System og fremgangsmåte for forvaltning av stigerørs livssyklus
BRPI0911949A2 (pt) método para determinar a permeabilidade de uma formação subterrânea e programa de computador armazenado numa mídia legível por computador
IL219210A0 (en) Biomarkers and methods for measuring and monitoring inflammatory disease activity
ES2402426T8 (es) Sonda médica
DK2232269T3 (da) Fremgangsmåder til biomarkører til diagnosticering og monitorering af psykotiske forstyrrelser
EP2009611A4 (en) ROAD SHARING LINE DETECTOR
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
FI20096188A0 (fi) Nutrigeneettisiä biomarkkereita lihavuudelle ja tyypin 2 diabetekselle
EP1846576A4 (en) BIOMARKERS OF TISSUE STATUS
FI20090289A0 (fi) Laitteisto ja menetelmä jarrun kunnon valvomiseksi
BRPI0919521A2 (pt) sistemas e métodos para a pré-diluição de edulcorantes
BRPI0920850A2 (pt) novos compostos e sua utilização
BRPI0813262A2 (pt) Biomarcadores de destruição de articulação para terapia de doença inflamatória de articulação anti-il-17a
BRPI0918157A2 (pt) acessório em y para raspa-tubos
DE602007008778D1 (de) Flüssigentwickler
EP2069683A4 (en) MICRO-DIFFRACTIVE MONITORING ILLUMINATOR
BRPI0906080A2 (pt) Metodos e sistema para avaliar a quantidade de óleo para fritura
FI20065734L (fi) Laite ja menetelmä suorituksen seuraamiseksi
FI20096217A7 (fi) Menetelmä ja laitteisto liikenneväylän päällysteen kunnon arvioimiseksi
EP2022201A4 (en) MULTIMEDIA SEGMENT MONITORING
BRPI0719234A2 (pt) Dispositivo para montagem e desmontagem de uma sonda, e, arranjo para acomodação de sonda
BRPI0810824A2 (pt) Linha coletora para monitoramento de vazamentos e localização de vazamentos
BRPI0924560A2 (pt) Métodos e kits para detectar, diagnosticar e monitorar doenças

Legal Events

Date Code Title Description
FD Application lapsed